J. Kellogg Parsons, M.D., M.H.S. Title and Address Associate Professor of Surgery
Transcription
J. Kellogg Parsons, M.D., M.H.S. Title and Address Associate Professor of Surgery
January 20, 2011 Curriculum Vitae J. Kellogg Parsons, M.D., M.H.S. Title and Address Associate Professor of Surgery Division of Urologic Oncology Moores UCSD Comprehensive Cancer Center 3855 Health Sciences Drive #0987 La Jolla, CA 92103-8897 (858) 822-6187 (office) (858) 822-6188 (fax) [email protected] Education 1992 A.B. in History Stanford University Palo Alto, CA 1997 M.D. University of Pennsylvania School of Medicine Philadelphia, PA 2005 Master of Health Science in Clinical Investigation The Johns Hopkins Bloomberg School of Public Health Baltimore, MD 1997-1999 Internship and Junior Residency in General Surgery The Department of Surgery The Johns Hopkins School of Medicine Baltimore, MD 1999-2003 Residency in Urology The Brady Urological Institute The Johns Hopkins School of Medicine Baltimore, MD 2003-2005 Fellowship in Urologic Oncology and Clinical Investigation The Brady Urological Institute The Johns Hopkins School of Medicine Baltimore, MD Training J. Kellogg Parsons, M.D., M.H.S. Page 2 Professional Experience 2003-2005 Instructor of Urology The Brady Urological Institute The Johns Hopkins School of Medicine Baltimore, MD 2005-2010 Assistant Professor The Department of Surgery Division of Urology University of California, San Diego School of Medicine San Diego, CA 2010present Associate Professor The Department of Surgery Division of Urology University of California, San Diego School of Medicine San Diego, CA Recognition Awards and Honors • 1988-90 Member of Men’s Varsity Swim Team, Stanford University • 1988-90 Varsity Athletic Academic Honor Roll, Stanford University • 1992 Graduation with Honors in History, Stanford University • 1992 Graduation with Distinction, Stanford University • 1994 American Foundation for Urologic Disease Medical Student Research Fellow • 1996 Alpha Omega Alpha (junior year), University of Pennsylvania School of Medicine • 1997 Dr. Spencer Morris Prize for Academic and Clinical Achievement, University of Pennsylvania School of Medicine—the top academic award given to a member of the graduating class • 2001 First Prize, Clinical Research Essay Contest, American Urological Association, Mid-Atlantic Section • 2003 American Urological Association Gerald P. Murphy Scholar for Prostate Cancer Research • 2003 Bernard Schwartz Fellow in Urologic Oncology, Brady Urological Institute, Johns Hopkins Medical Institutions • 2005 Third Prize, Urology Resident/Fellow Research Essay Contest—an award given by a peer-reviewed journal 2 J. Kellogg Parsons, M.D., M.H.S. Page 3 • 2006 First Prize, American Urological Association/ACMI National Clinical Research Essay Contest • 2006 Commended Peer Reviewer for Annals of Internal Medicine • 2006 British Medical Association Medical Book Competition “Highly Commended” Award for Prostate Cancer: Principles and Practice • 2007 American Cancer Society Young Investigator Travel Scholarship Award • 2007 Valedictorian, UCSD National Council for Leadership in Academic Medicine Program • 2007 First Prize, American Urological Association Joseph McCarthy Clinical Research Essay Contest • 2008 Western Section Representative for the American Urological Association National Leadership Program—1 of only 2 urologists selected from the western U.S. • 2008 Honoree for Excellence in Clinical Care, National Doctor’s Day • 2008 Recipient, Hope for a Cure Foundation Cancer Research Grant • 2009 Second Prize, American Urological Association/ACMI National Clinical Research Essay Contest • 2009 First Prize, Moderated Poster Session, American Urological Association National Meeting, Chicago, IL • 2009 San Diego VA Medical Center Teamwork Award • 2009 Selected for America’s Best Doctors® —an independent, peer-elected international database • 2009 Journal of Urology Outstanding Reviewer of the Year Award • 2010 Fellow, American Urological Association/European Association of Urology International Academic Exchange Program—one of only 3 urologists selected from the U.S. • 2010 First Prize, American Urological Association Joseph McCarthy Clinical Research Essay Contest • 2010 San Diego County Medical Society and San Diego Magazine Physician of Exceptional Excellence (“Top Docs”) • 2010 Selected for Best Doctors® Educational Activities, University Service, and Community Service Teaching • 2001 Established the annual award for excellence in teaching presented by house officers to faculty members at The Brady Urological Institute, Johns Hopkins School of Medicine • 2007-pres Course Director, Urology Sub-internship Course, UCSD Medical School 3 J. Kellogg Parsons, M.D., M.H.S. Page 4 • 2009 Course Director, American Urological Association Western Section Review Course on Benign Prostatic Hyperplasia, October 26, 2009. Lectures • 2006 Faculty Presenter for UCSD Division of Family Medicine Grand Rounds “PSA Screening: A Practical Review,” February 8, 2006. • 2006 Faculty Presenter for UCSD Topics and Advances in Internal Medicine conference, “PSA Screening: A Practical Review March 6, 2006. • 2006 Presentation for San Diego Society of Urological Nursing at the VA Medical Center, “Minimal-Invasive Urological Surgery,” June 9, 2006. • 2007 Faculty Presenter for UCSD Department of General Surgery Grand Rounds, “Minimally-Invasive Prostate Surgery,” February 21, 2007. • 2007 Faculty Presenter for UCSD Topics and Advances in Internal Medicine conference, “Prostate Cancer Screening: A Practical Approach,” February 26, 2007. • 2007 Faculty Presenter for UCSD Stein Institute for Research in Aging Public Lecture Series, “The Prostate: Everything You Always Wanted to Know, But Were Afraid to Ask,” March 21, 2007. • 2007 Faculty Presenter for Moores UCSD Comprehensive Cancer Center Faculty Ambassador Series, “Tomatoes, Broccoli, and Fish: New Insights into the Prevention and Treatment of Prostate Cancer,” September 11, 2007. • 2007 Faculty Presenter for UCSD Stein Institute for Research in Aging Grand Rounds, “Active Surveillance for Prostate Cancer,” November 5, 2007. • 2008 Faculty Presenter for UCSD/Balboa Naval Hospital Community Grand Rounds, “Surgery for High Risk Prostate Cancer,” January 12, 2008. • 2008 Faculty Presenter for UCSD Challenging Cases in Urologic Oncology Course, “Update on Renal Cryosurgery and RFA,” February 29, 2008. • 2008 Faculty Presenter for UCSD Challenging Cases in Urologic Oncology Course, “Diet and Prostate Cancer,” March 1, 2008. • 2008 Faculty Presenter for the UCSD Topics and Advances in Internal Medicine conference, “Erectile Dysfunction,” March 7, 2008 4 J. Kellogg Parsons, M.D., M.H.S. Page 5 • 2008 Presentation for the San Diego Prostate Cancer Research and Education Foundation (a community-based patient advocacy group), “Diet and Prostate Cancer: A Practical Approach for Patients,” June 14, 2008 • 2008 Presentation for the San Diego Clairemont Hills Kiwanis Club, “Preventing Prostate Cancer,” July 23, 2008 • 2008 Invited Faculty Member for the City of Hope Cancer Center New Technologies and Innovative Strategies for GU Malignancies Course, “Prevention of Prostate Cancer: Recent Developments,” September 14, 2008 • 2008 Faculty Presenter for UCSD/Balboa Naval Hospital Community Grand Rounds, “Robotic-Assisted Pyeloplasty,” October 12, 2008. • 2008 Invited Speaker for NIH/NIDDK Workshop on Modifiable Risk Factors for Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS) in Bethesda, MD, “Inflammation and Epidemiologic Studies of BPH/LUTS,” October 13, 2008 • 2008 Invited Faculty Lecturer, University of California, Santa Barbara Department of Engineering, “Robotic Prostate Surgery: Separating Hype from Reality,” November 17, 2008 • 2008 Faculty Presenter for UCSD Stein Institute for Research in Aging Public Lecture Series, “Prostate Cancer: What Every Man Should Know,” November 19, 2008. • 2008 Faculty Presenter for UCSD Stein Institute for Research in Aging Grand Rounds, “Robotic Prostate Surgery: Separating Hype from Reality,” November 24, 2008. • 2008 Faculty Presenter for UCSD Department of General Surgery Grand Rounds, “Surgery for Prostate Cancer: An Evidence-Based Critique,” December 10, 2008. • 2009 Faculty Presenter for the UCSD Postgraduate Urology Course, “Prostate Cancer Prevention: Principles and Practice,” February 21, 2009. • 2009 Faculty Presenter for the UCSD Postgraduate Urology Course, “Active Surveillance of Prostate Cancer,” February 21, 2009. • 2009 Faculty Presenter for the UCSD Postgraduate Urology Course, “Salvage Cryotherapy for Prostate Cancer,” February 21, 2009. 5 J. Kellogg Parsons, M.D., M.H.S. Page 6 • 2009 Faculty Presenter for the Moores UCSD Cancer Center Special Seminar Series, “Prostate Cancer Prevention: Principles and Promise,” February 25, 2009. • 2009 Invited Lecturer for the NIH/NIDDK Conference on Urologic Complications of Obesity and Diabetes, “Adiposity, Benign Prosatic Hyperplasia, and Lower Urinary Tract Symptoms,” March 10, 2009, Baltimore, MD. • 2009 Invited Speaker, Roswell Park Cancer Institute Special Seminar, “Prevention of Bladder Cancer: Principles and Therapeutic Promise,” March 13, 2009, Buffalo, New York. • 2009 Faculty Presenter for UCSD Division of Internal Medicine Conference, “PSA Screening: A Practical Review,” March 25, 2009. • 2009 Faculty Presenter for UCSD Stein Institute for Research in Aging Public Lecture Series, “Diagnosis of and Treatment for Prostate Cancer,” September 16, 2009. • 2009 Faculty Presenter for Moores UCSD Public Lecture Series, “Active Surveillance for Prostate Cancer,” September 17, 2009. • 2009 Presentation for the Clairemont Rotary Club, “Diagnosis of and Treatment for Prostate Cancer,” September 25, 2009 • 2009 Speaker for the American Urological Association Western Section Review Course on Benign Prostatic Hyperplasia, “Epidemiology, Pathophysiology, and Natural History of BPH,” October 26, 2009 • 2009 Speaker for the American Urological Association Western Section Review Course on Benign Prostatic Hyperplasia, “Clinical Evaluation, Diagnosis, and Treatment Guidelines,” October 26, 2009 • 2009 State of the Art Lecturer, Cancer and Leukemia Group B Genitourinary Committee National Meeting, “Dietary Interventions for Genitourinary Cancers: Strategies for a Post-SELECT Era,” November 14, 2009, Phoenix, AZ. • 2009 Faculty Presenter for UCSD Stein Institute for Research in Aging Grand Rounds, “Active Surveillance for Prostate Cancer,” December 14, 2009. • 2010 Faculty Presenter for the UCSD Topics and Advances in Internal Medicine conference, “Early Diagnosis of Prostate Cancer: Blessing or Curse?” March 9, 2010 6 J. Kellogg Parsons, M.D., M.H.S. Page 7 • 2010 Faculty Presenter for UCSD Division of Urology Professor’s Rounds, “Prostate Cancer Epidemiology and Prevention,” March 10, 2010 • 2010 Moderator, Prostate Cancer Session, UCSD Postgraduate Urology Course, March 14, 2010 • 2010 Faculty Presenter for the UCSD Postgraduate Urology Course, “Active Surveillance of Prostate Cancer,” March 14, 2010. • 2010 Faculty Presenter for the UCSD Postgraduate Urology Course, “Epidemiology, Pathophysiology, and Natural History of BPH,” March 15, 2010. • 2010 Faculty Presenter for the UCSD Postgraduate Urology Course, “EvidenceBased Principles and Outcomes of Medical Management for BPH,” March 15, 2010. • 2010 Invited Lecturer, “Prevention of BPH,” Slovak Medical University, Bratislava, Slovakia, April 1, 2010. • 2010 Invited Lecturer, “Modifiable Risk Factors for BPH,” LudwigMaximillians-Universitat, Munich, Germany, April 7, 2010. • 2010 Invited Lecturer, “Prevention of BPH,” University of Padua, Padua, Italy, April 9, 2010. • 2010 Invited Lecturer, “Dietary Interventions for Prostate Cancer,” Hospital Universitario Fundacion Alcoron, Madrid, Spain, April 13, 2010. • 2010 Faculty Presenter for UCSD Stein Institute Geriatrics Seminar Series, “Benign Prostatic Hyperplasia,” May 7, 2010. • 2010 Invited Lecturer, Scripps Hospital Family Practice Residency Program Lecture Series, “Evidence-Based Principles of Medical Management for BPH,” August 25, 2010. • 2010 Professor’s Lecture, UCSD Division of Urology, “Bioethics,” October 25, 2010. University Service • 2003-2004 • 2007-08 • 2007-pres Member, Johns Hopkins Medical School Sub-Committee on Graduate Medical Education Member, UCSD Moores Cancer Center Faculty Retreat Planning Committee Member, UCSD Medical Center Technology Assessment Committee 7 J. Kellogg Parsons, M.D., M.H.S. Page 8 • • • 2010 2010 2011 Faculty Panel Participant, LCME Site Visit for UCSD Medical School Chairman, UCSD Department of Surgery Ad Hoc Promotions Committee Invited Panel Member, Moores UCSD Cancer Center Annual Retreat Community Service • 2007 • 2007-pres • 2009-pres Faculty Mentor, UCSD Medical School High School Summer Training on Aging Research Program UCSD Site Administrator for Improving Access, Counseling and Treatment for Californians with Prostate Cancer (IMPACT) Program Physician Mentor for the UCSD Physician Enhancement Program: a program designed to promote public protection, patient safety, and the attainment of the highest possible quality of clinical care through mentoring of at-risk physicians. Editorial Activities • 2000-pres Expert reviewer for Urology • 2004-pres Expert reviewer for British Journal of Urology International, Prostate Cancer and Prostatic Diseases, American Family Physician, and Asian Journal of Andrology • 2005-pres Expert reviewer for Journal of Urology, Annals of Internal Medicine, and Journal of Laparoendoscopic Advanced Surgical Techniques • 2006-pres Expert reviewer for Cancer and Science of the Total Environment • 2007-pres Expert reviewer for Clinical Drug Investigation • 2008-pres Expert reviewer for The Prostate • 2009-pres Expert reviewer for World Journal of Urology • 2009-pres Expert reviewer for Cancer Prevention • 2010-pres Expert reviewer for the Journal of Hepatology • 2010-pres Expert reviewer for the Journal of the American Medical Association • 2010-pres Expert reviewer for the Journal of the American College of Surgeons • 2010-pres Expert reviewer for the Journal of Clinical Oncology • 2010-pres Expert reviewer for TSW Urology • 2010-pres Expert reviewer for The Aging Male • 2011 Expert reviewer for Maturitas Clinical Activities Certification • 2002-2006: • 2005-pres • 2007-pres Maryland State Medical License California State Medical License Diplomat, American Board of Urology Organizational Activities Professional Societies Membership • American Urological Association • Alpha Omega Alpha Medical Honor Society 8 J. Kellogg Parsons, M.D., M.H.S. Page 9 • • • • American Association of Clinical Urologists San Diego Urological Association San Diego County Medical Society California Medical Association National Organizations • 2008-pres Reviewer for the American Urological Association National Content Review Sub-Committee • 2009-pres Member, American Urological Association National Practice Guidelines Committee • 2009-pres Member, American Urological Association National Steering Committee for Evidence Based Reviews in Urology • 2010 Co-chair, American Urological Association National Content Review SubCommittee • 2010 Member, American Urological Association National Young Urologists Committee Research Activities Grants Active 2 P30 CA23100-23 (Carson) 06/01/07 - 04/30/12 0.6 calendar months NIH/NCI $19,830,000 Specialized Cancer Center Support Grant: The major goal of this project is to develop novel initiatives for cancer prevention and control. Role: Staff Investigator PC073412 (Parsons) 09/27/08-09/26/13 9 calendar months Department of Defense $699, 214 Feasibility Study of a Novel Diet-Based Intervention for Prostate Cancer The major goals of this project are to assess the effect of a dietary intervention on clinical progression and quality of life in prostate cancer patients treated with active surveillance. Role: PI CA037447-25 (Parsons) 6/1/08-5/31/11 0.6 calendar months NIH/NCI $77,000.00 A pilot trial of diet change for superficial bladder cancer. The major goal of this project is to assess the feasibility of a diet-based intervention for the treatment of bladder cancer. Role: PI R21DK083675 (Marshall and Parsons) 9/1/10-8/30/12 1.2 calendar months NIH/NIDDK $250,000 Risk factors for lower urinary tract symptom progression among older men. 9 J. Kellogg Parsons, M.D., M.H.S. Page 10 The major goals of this project are to assess the effect of modifiable risk factors on the initiation and clinical progression of lower urinary tract symptoms in older men and to develop clinically useful risk prediction models for lower urinary tract symptoms. Role: PI U01-AG-030644-01A1 (Snyder) 2009-20015 0.12 calendar months NIH/NIA $2,100,000 The testosterone study. The major goal of this project is to assess the efficacy of testosterone replacement therapy for the treatment of symptomatic hypogonadism in older men. Role: Co-Investigator Research Organizations and Programs Organizations • 2006-pres • 2007-pres Committees • 2006-09 • 2007-09 • 2007-pres • 2007-08 • 2008-pres • 2008-pres • 2010 Member, National Cancer Institute Southwest Oncology Group Member, National Cancer Institute Cancer and Leukemia Group B Member, National Steering Committee, Selenium and Vitamin E Cancer Prevention Trial (SELECT) Member, National Committee on Retention and Adherence, Selenium and Vitamin E Cancer Prevention Trial (SELECT) Member, Cancer and Leukemia Group B Sub-committee on Genitourinary Surgery NIH/NIDDK Planning Committee Member, Workshop on Modifiable Risk Factors for Lower Urinary Tract Symptoms Member, Cancer and Leukemia Group B Sub-committee on Cancer Prevention Member, Cancer and Leukemia Group B Committee on Genitourinary Disease Nominated for Cancer and Leukemia Group B Executive Committee Leadership Positions • 2008-pres Study Protocol Chair, Cancer and Leukemia Group B Study #70807: “A Randomized Multicenter Phase III Study of Diet Change for Prostate Cancer Patients Treated With Active Surveillance: The Men’s Eating and Living (MEAL) Study” • 2010-pres Team Leader for Localized Prostate Cancer, Cancer and Leukemia Group B Genitourinary Disease Committee Panels and Programs • 2006 Invited Participant, NIH/NIDDK Workshop on Modifiable Risk Factors for Lower Urinary Tract Symptoms, Pasadena, CA 10 J. Kellogg Parsons, M.D., M.H.S. Page 11 • 2007 • 2008 • 2008 • 2008 • 2008 • 2009 • 2009 • 2009 • 2010 Invited Panel Member, NIH/NIDDK Prostate Research Strategic Planning Group Meeting, Baltimore, MD Invited Panel Member, NIH/NIDDK Workshop on Modifiable Risk Factors for Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS), Bethesda, MD Study Section Member, Scientific Grant Review, Department of Defense, Reston, VA Invited Moderator, NIH/NIDDK Workshop on Modifiable Risk Factors for Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS), Bethesda, MD Invited Moderator, Prostate Cancer Session, American Urological Association Annual Western Section Meeting, Monterrey, CA Invited Panel Member, NIH/NIDDK Conference on Urologic Complications of Obesity and Diabetes, Baltimore, MD Invited Lecturer, Roswell Park Cancer Institute, Buffalo, New York Invited Panel Member, NIH/NIDDK Urologic Diseases of America Conference on Modifiable Risk Factors for Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS), Santa Monica, CA Invited Participant, Prostate Cancer Foundation Workshop on Active Surveillance for Prostate Cancer, Washington, D.C. Publications Peer-Reviewed 1. Kwon HY, Longhurst PA, Parsons K, Wein AJ, and Levin RM. Effects of partial outlet obstruction on bladder-strip sensitivity to glucose deprivation: an in vitro study in the rat. World J Urol 14: S38-42, 1996. 2. Kwon HY, Longhurst PA, Parsons K, Wein AJ, and Levin RM. Effects of glucose deprivation on the contractile response of the rabbit bladder to repetitive stimulation. Neurourol Urodynam 15: 71-78, 1996. 3. Parsons JK, Malkowicz SB, and Torosian MH. A simplified procedure for creating a urinary conduit in patients with a colostomy. Oncology Rep 6: 451-3, 1999. 4. Parsons JK and Schoenberg MP. Successful conservative management of perforated ileal neobladder. J Urol 165: 1214-1215, 2001. 5. Parsons CL, Zupkas P, and Parsons JK. Intravesical potassium sensitivity in interstitial cystitis and urethral syndrome patients. Urology 57: 428-33, 2001. 6. Parsons JK, Schoenberg MP, and Carter HB. Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology 57: 1013-15, 2001. 11 J. Kellogg Parsons, M.D., M.H.S. Page 12 7. Parsons JK and Schoenberg MP. Renal artery pseudoaneurysm occurring after partial nephrectomy. Urology 58: 105, 2001. 8. Parsons JK, Nelson CP, Gage WR, Nelson WG, and De Marzo AM. GSTA1 expression in normal, pre-neoplastic, and neoplastic human prostate tissue. Prostate 49: 30-37, 2001. 9. Parsons JK, Gage WR, Nelson WG, and De Marzo AM. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Urology 58: 619-24, 2001. 10. Parsons JK, Jarrett TW, Lancini V, and Kavoussi LR. Infundibular stenosis following percutaneous nephrolithotomy. J Urol 167: 35-38, 2002. 11. Ramakumar S, Lancini V, Chan DY, Parsons JK, Kavoussi LR, and Jarrett TW. Laparoscopic pyeloplasty with concomitant pyelolithotomy. J Urol 167: 1378-1380, 2002. 12. Parsons JK, DeMeester SL, and Gearhart JP. Vaginal reconstruction utilizing sigmoid colon: complications and long-term results. J Pediat Surg 37: 629-33, 2002. 13. Parsons JK, Jarrett TW, Chow GK, and Kavoussi LR. The effect of prior abdominal surgery on urological laparoscopy. J Urol 168: 2387-90 2002. 14. Parsons JK, Ferrer F, and Docimo SG. The low scrotal approach to the ectopic or ascended testicle: prevalence of a patent processus vaginalis. J Urol 169: 1832-33, 2003. 15. Parsons JK, Tufaro A, Chang B, and Schoenberg MP: Vaginal and pelvic floor reconstruction following exenterative surgery utilizing a rectus abdominis myocutaneous flap. Urology 61: 1249-53, 2003. 16. Parsons JK, Lancini V, Shetye K, Regan F, Potter SR and Jarrett TW. Urinary stone size: comparison between abdominal plain radiography and non-contrast CT measurements. J Endourol 17: 725-728, 2003. 17. Parsons JK and Parsons CL. The historical origins of interstitial cystitis. J Urol 171: 2022, 2004. 18. Rieder JMD, Moresi JM, and Parsons JK. Pyoderma vegetans of the penis. J Urol, 171: 354, 2004. 19. Parsons JK, Varkarakis I, Rha KH, Jarrett TW, Pinto PA and Kavoussi LR. Complications of abdominal laparoscopic surgery: 5-year longitudinal analysis. Urology 63: 27-32, 2004. 12 J. Kellogg Parsons, M.D., M.H.S. Page 13 20. Parsons JK, Freeswick P, and Jarret TW. Appendiceal cystadenoma mimicking a cystic renal mass. Urology 63: 981-982, 2004. 21. Lowentritt B, Parsons JK, Argami P, and Gearhart JP. Pediatric epithelioid sarcoma of the penis. J Urol 172: 296-297, 2004. 22. Parsons JK and Partin AW. Applying complexed prostate-specific antigen (cPSA) to clinical practice. Urology 63: 815-818, 2004. 23. Parsons JK, Brawer MK, Cheli CD, Partin AW, and Djavan B. Complexed prostatespecific antigen reduces unnecessary prostate biopsies in the 2.6 to 4.0 ng/ml total PSA range. BJU Int 94: 47-50, 2004. 24. Parsons JK and Wright EJ. Extraction of UroLume® endoprostheses with one-stage urethral reconstruction. Urology 64: 582-4, 2004. 25. Parsons JK, Marschke P, Maples P, and Walsh PC. The effect of methylprednisolone on the return of sexual function after nerve sparing radical retropubic prostatectomy. Urology, 64: 987-990, 2004. 26. Carter HB, Landis P, Wright EJ, Parsons JK, and Metter EJ. Can a baseline PSA level identify men who will develop lower urinary tract symptoms later in life? J Urol 173: 2040-2043, 2005. 27. Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P, and Metter EJ. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev 14: 2257-2260, 2005. 28. Rieder JMD, Parsons JK, Gearhart JP, and Schoenberg M. Primary squamous cell carcinoma in unreconstructed exstrophic bladder. Urology 67: 199e1-199e2, 2006. 29. Stanford EJ, Mattox TF, Parsons JK, and McMurphy C. Prevalence of benign microscopic hematuria among women with interstitial cystitis: implications for evaluation of genitourinary malignancy. Urology, 67: 946-949, 2006. 30. Parsons JK and Partin AW. Clinical interpretation of prostate cancer biopsy reports. Urology 67: 452-457, 2006. 31. Parsons GN, Siberry GK, Parsons JK, Christensen JR, Joyner ML, Lee SL, Kiefner CM, and Hutton N. Multidisciplinary, inpatient directly observed therapy for HIV-1-infected children and adolescents failing HAART: A retrospective study. AIDS Patient Care and STDs 20: 275-284, 2006. 32. Parsons JK, Carter HB, Partin AW, Windham G, Metter EJ, and Platz EA. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 91: 25622568, 2006. 13 J. Kellogg Parsons, M.D., M.H.S. Page 14 33. Parsons JK, Hergan LA, Sakamoto K, and Lakin C. Efficacy of alpha blockers for the treatment of ureteral stones. J Urol 177: 983-987, 2007. 34. Parsons JK, Sokoll L, Trock B Partin AW. Validity of complexed prostate-specific antigen for diagnosing biochemical recurrence after radical retropubic prostatectomy. BJU Int 99: 758-761, 2007. 35. Hergan L, Kashefi C, and Parsons JK. Local anesthetic decreases pain associated with transrectal ultrasound-guided prostate biopsy: a meta-analysis. Urology 69: 520-525, 2007. 36. Parsons JK, Kurth K, and Sant GR. Epidemiological issues in interstitial cystitis. Urology 69 (4 Suppl): S5-8, 2007. 37. Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 178: 395-401, 2007. 38. Parsons JK, Bergstrom J, and Barrett-Connor E. Serum lipids and risk of benign prostatic hyperplasia in community-dwelling men. BJU Int, 101:313-8, 2008. 39. Parsons JK, Newman V, Mohler JL, Pierce JP, Flatt S, and Marshall J. Dietary modification in prostate cancer patients on active surveillance: a randomized, multicenter feasibility study. BJU Int, 101: 1227-1231, 2008. 40. Silberstein J, Grabowski J, and Parsons JK. Use of vacuum-assisted device for Fournier’s gangrene. Rev Urol, 10:76-80, 2008. 41. Kashefi CK, Messer K, Barden R, Sexton C, and Parsons JK. Incidence and prevention of iatrogenic urethral injuries. J Urol, 179:2254-7, 2008. 42. Parsons JK and Kashefi CK. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol, 53:1228-35, 2008. 43. Sandhu AP, Senthi R, Rice R, Wang, J, Marcus L, Salem C, Downs T, Parsons JK, Millard F, Pawlicki T, and Mundt A. Prostate bed localization with image-guided approach using On-Board Imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomy. Radiother Oncol, 88:20-5, 2008. 44. Parsons JK, Bergstrom J, Silberstein J, and Barrett-Connor E. Prevalence and characteristics of lower urinary tract symptoms in men aged 80 years and older. Urology, 72:318-21, 2008. 45. Parsons JK and Bennett L. Outcomes of radical retropubic, laparoscopic, and roboticassisted prostatectomy. Urology, 72:412-6, 2008. 14 J. Kellogg Parsons, M.D., M.H.S. Page 15 46. Parsons JK, Newman V, Mohler J, Pierce JP, Paskett E, and Marshall J. The Men’s Eating and Living (MEAL) Study: A Cancer and Leukemia Group B pilot trial of dietary intervention for the treatment of prostate cancer. Urology, 72: 633-7, 2008. 47. Silberstein J and Parsons JK. Current concepts in diet and prostate cancer. Aging Health, 4: 495-50, 2008. 48. Silberstein J, Lakin C, and Parsons JK. Shock wave lithotripsy and renal hemorrhage. Rev Urol, 10: 236–241, 2008. 49. Farhat GN, Taioli E, Cauley JA, Zmuda JM, Orwoll E, Bauer DC, Wilt TJ, Hoffman AR, Beer TM, Shikany JM, Daniels N, Chan J, Fink HA, Barrett-Connor E, Parsons JK, Bunker CH, for the Osteoporotic Fractures in Men (MrOS) Study Group. Association of bone mineral density with prostate cancer risk: the Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev, 18:148-154, 2009. 50. Lippman SL, Klein EA, Goodman PJ, Lucia MS, Thompson IA, Ford LJ, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Philip Walther P, Lieber MM, Klotz L, Kristal A, Ganz PA, Santella RM, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Baker LH, and Coltman CA. The Selenium and Vitamin E Cancer Prevention Trial (SELECT): Southwest Oncology Group Study S0000. JAMA, 301: 3951, 2009. 51. Parsons JK, Saria E, Nakayama M, Mitchell R, Samathanam CA, and De Marzo AM. Mutational analysis of p63 in prostate cancer cells. Prostate, 69: 559-569, 2009. 52. Silberstein J and Parsons JK. Hand assisted and total laparoscopic nephrectomy: a comparison. JSLS, 13(1):36-43, 2009. 53. Parsons JK, Mougey J, Lambert L, Wilt T, Fink H, Garzotto M, Barrett-Connor E, and Marshall L, for the Osteoporotic Fractures in Men (MrOS) Study Group. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int, 104:63-68, 2009. 54. Parsons JK, Newman V, Mohler JL, Pierce JP, Flatt S, Messer K, and Marshall J. Dietary intervention after definitive therapy for localized prostate cancer: results from a pilot study. Can J Urol, 16(3):4648-4654, 2009. 55. Parsons JK and Im R. Alcohol consumption is associated with decreased risk of benign prostatic hyperplasia. J Urol, 182:1463-8, 2009. 56. Sarma AV and Parsons JK. Diabetes and benign prostatic hyperplasia: emerging clinical connections. Curr Urol Rep, 10:267-275, 2009. 15 J. Kellogg Parsons, M.D., M.H.S. Page 16 57. Sarma AV, Parsons JK, McVary K, and Wei JT. Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms: what do we know? J Urol, 182: S32-S37, 2009. 58. Parsons JK, Sarma AV, McVary K, and Wei J. Obesity and benign prostatic hyperplasia: clinical connections and emerging paradigms. J Urol, 182: S27-S31, 2009. 59. Parsons JK, Kwan L, Connor S, Miller D, and Litwin M. Prostate cancer treatment in economically disadvantaged men: a comparison of county hospitals and private providers. Cancer, 116(5):1378-1384, 2010. 60. Silberstein J and Parsons JK. Evidence based principles of diet and bladder cancer. Urology, 75(2):340-346, 2010. 61. Fujita K, Ewing CM, Getzenberg RH, Parsons JK, Isaacs WB, Pavlovich CP. Monocyte chemotactic protein-1 (MCP-1:CCL2) is associated with prostatic growth dysregulation. Prostate, 70(5):473-8, 2010. 62. Parsons JK, Wilt TJ, Wang P, Barrett-Connor E, Bauer DC, and Marshall LM, for the Osteoporotic Fractures in Men (MrOS) Study Group. Progression of lower urinary tract symptoms among older men: a community based study. J Urol, 183: 1915-1920, 2010. 63. Trifiro MD, Parsons JK, Bergstrom J, Palazzi-Churas K, and Barrett-Connor E. Serum sex hormones and 20-year risk of lower urinary tract symptoms in community dwelling older men. BJU Int, 105: 1554-9, 2010. 64. Parsons JK, Palazzi-Churas K, Bergstrom J, and Barrett-Connor E. A prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study. J Urol, 184: 1040-4, 2010 65. Nath SK, Sandhu AP, Rose BS, Simpson DR, Nobiensky PD, Wang JZ, Millard F, Kane CJ, Parsons JK, and Mundt AJ. Toxicity analysis in post-operative image-guided intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 78: 435-4, 2010. 66. Silberstein JL and Parsons JK. Prostate cancer prevention: concepts and clinical recommendations. Prostate Cancer Prostatic Dis, 13: 300-6, 2010. 67. Silberstein JL, Parsons JK, Palazzi-Churas K, Downs TM, Derweesh IH, Woldrich J, and Kane CJ. Robot assisted laparoscopic radical prostatectomy in men with human immunodeficiency virus. Prostate Cancer Prostatic Dis, 13: 328-32, 2010. 68. Nath SK, Sandhu AP, Sethi RA, Jensen LG, Rosario MD, Kane CJ, Parsons JK, Millard FE, Jiang SB, Rice RK, Pawlicki T, and Mundt AJ. Target localization and toxicity in dose-escalated prostate radiotherapy with image-guided approach using daily planar kilovoltage imaging. Technol Cancer Res Treat 10(1):31-7, 2011. 16 J. Kellogg Parsons, M.D., M.H.S. Page 17 69. Ward NT, Parsons JK, Levinson AW, Bagga HS, Mettee LZ, Su LM, and Pavlovich CP. Prostate size is not associated with recovery of sexual function after minimally invasive radical prostatectomy. Urology, in press. 70. Woldrich JM, Palazzi-Churas K, Lakin C, Albo M and Parsons JK. Laser photovaporization of the prostate for urinary retention. BJU Int, in press. 71. Kopp RP, Parsons JK, Shiau J, Wang-Rodriguez J, Silberstein JL, Derweesh IH, Cohen SA, Kane CJ, Downs TM, and Sakamoto K. Prostate atypia: clinical and pathologic variables associated with cancer diagnosis on repeat biopsy. Prostate Cancer Prostatic Dis, in press. 72. Kopp RP, Han M, Partin AW, Humphries E, Freedland SJ, and Parsons JK. Obesity and prostate enlargement in men with localized prostate cancer. BJU Int, in press. 73. Stroup SP, Palazzi-Churas K, Kopp RP, and Parsons JK. U.S. trends in hospitalizations for benign prostatic hyperplasia, 1998-2008. BJU Int, in press. 74. Parsons JK, Messer K, White M, Barrett-Connor E, Bauer DC, and Marshall L, for the Osteoporotic Fractures in Men (MrOS) Study Group. Excess body weight, physical activity, and urinary symptoms in older men. In peer review. 75. Parsons JK, Schenk J, Messer K, and Kristal A. Finasteride and the risk of incident symptomatic benign prostatic hyperplasia. In process. Invited Reviews and Editorials 1. Parsons JK and Partin AW. Hugh Hampton Young, benign prostatic hyperplasia, and “The Cure of Prostatic Obstruction.” J Am Coll Surg, 201: 654-655, 2005. 2. Parsons JK. Editorial comment on Babaian RJ, Naya Y, Cheli C, et al: The detection and potential economic value of complexed prostate-specific antigen as a first line test. J Urol 175: 901, 2006. 3. Parsons JK. An Illustrated Pocketbook of Prostatic Diseases. Urology 67: 870-871, 2006. 4. Parsons JK. BPH and the public health: have we lost the forest through the trees? J Urol, 179:S81, 2008. 5. Parsons JK. Therapeutic Strategies in Prostate Cancer. BJU Int. 2008 Jul; 102(1):130. 6. Parsons JK. Editorial comment. J Urol 182: 624-625, 2009. 17 J. Kellogg Parsons, M.D., M.H.S. Page 18 7. Parsons JK. Editorial comment. J Urol 182:1340-1, 2009. 8. Parsons JK. Editorial comment. Urology 76(3): 55, 2010. 9. Parsons JK. Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms. Curr Opin Urol 21:1-4, 2011. 10. Parsons JK. BPH and LUTS: epidemiology and risk factors. Curr Bladder Dysfunction Reports, in press. Letters 1. Parsons JK. A shift sorely needed. Penn Medicine 16 (3): 2, 2004. 2. Parsons JK and Partin AW. Response to re: applying complexed prostate-specific antigen (cPSA) to clinical practice. Urology 65: 629-630, 2005. Abstracts 1. Parsons JK, Nelson CP, Gage WR, Nelson WG, De Marzo AM. Expression of glutathione S- transferase alpha in human prostate. Annual Meeting of the Society for Urologic Oncology: National Institutes of Health, Bethesda, MD; December 2–3, 2000. 2. Parsons JK, Nelson CP, Gage WR, Nelson WG, De Marzo AM. Expression of glutathione S- transferase alpha in normal, pre-neoplastic, and neoplastic human prostate tissue. Annual Meeting of the United States and Canadian Academy of Pathology: Atlanta, GA; March 5, 2001. 3. Parsons JK, Nelson CP, Gage WR, Nelson WG, De Marzo AM. Expression of glutathione S- transferase alpha in human prostate. Annual Meeting of the American Association for Cancer Research: New Orleans, LA; March 25, 2001. 4. Parsons JK, Nelson CP, Gage WR, Nelson WG, De Marzo AM. GSTA1 expression in normal, pre-neoplastic, and neoplastic human prostate tissue. Annual Meeting of the American Urological Association: Anaheim, CA; June 4, 2001. 5. Parsons JK, DeMeester SL, Gearhart JP. Vaginal reconstruction utilizing sigmoid colon: complications and long-term results. Annual Meeting of the American Urological Association: Anaheim, CA; June 3, 2001. 6. Parsons JK, Roberts WW, Chow GK, Jarrett TW, Kavoussi LR. Urological laparoscopy after previous abdominal surgery. Annual Meeting of the American Urological Association: Anaheim, CA; June 2, 2001. 18 J. Kellogg Parsons, M.D., M.H.S. Page 19 7. Parsons JK, Saria EA, Gage WR, Nelson WG, De Marzo AM. Diminished p63 protein expression in prostate adenocarcinoma. Annual Meeting of the Mid-Atlantic Section of the American Urological Association: Hot Springs, VA; October 15, 2001. 8. Parsons JK, Ferrer F, Docimo SG. The scrotal approach to the ectopic or ascended testicle: incidence of patent processus vaginalis. Annual Meeting of the American Urological Association: Orlando, Fl; May 26, 2002 9. Parsons JK, Teichman J, Parsons CL. Interstitial cystitis: a historical review. Annual Meeting of the American Urological Association: Orlando, Fl; May 27, 2002. 10. Parsons JK, Mitchell R, De Marzo AM. Mutational analysis of the p63 gene in prostate cancer. Annual Meeting of the Mid-Atlantic Section of the American Urological Association: Baltimore, MD; October 5, 2002. 11. Parsons JK, Varkarakis I, Rha KH, Jarrett TW, Pinto PA, Kavoussi LR. Complications of abdominal laparoscopic surgery: a 5-year longitudinal analysis. Annual Meeting of the American Urological Association: Chicago, Ill; April 27, 2003. 12. Parsons JK, Mitchell R, De Marzo AM. Mutational analysis of the p63 gene in prostate cancer cells. Annual Meeting of the American Urological Association: San Francisco, CA; May, 2004. 13. Parsons JK, Matthews R, Su LM, Allaf MA, Gearhart JP. Laparoscopic-assisted sigmoid vaginoplasty. Annual Meeting of the American Urological Association: San Francisco, CA; May, 2004. 14. Parsons JK, Carter HB, Landis P, Platz E, Wright EJ, Metter EJ. Higher free testosterone index is associated with increased prostate cancer risk: results from the Baltimore Longitudinal Study on Aging. Annual Meeting of the American Urological Association: San Francisco, CA; May, 2004. 15. Magi-Galluzzi C, Parsons JK, Fedor H, Miller G, De Marzo AM. The prevalence and extent of autopsy benign prostatic hyperplasia is less in southeast Asian men than North American men. Annual Meeting of the American Urological Association: San Francisco, CA; May, 2004. 16. Magi-Galluzzi C, Parsons JK, Fedor H, Miller G, De Marzo AM. The prevalence and extent of autopsy prostate cancer is less in southeast Asian men than North American men. Annual Meeting of the American Urological Association: San Francisco, CA; May, 2004. 17. Parsons JK, Mitchell R, De Marzo AM. Differential expression of p63 mRNA variants in normal prostate and prostatic adenocarcinoma. Annual Meeting of the American Urological Association: San Francisco, CA; May, 2004. 19 J. Kellogg Parsons, M.D., M.H.S. Page 20 18. Parsons JK, Sokoll L, Trock B, Partin AW. Validity of complexed prostate specific antigen for the diagnosis of biochemical recurrence after radical retropubic prostatectomy. Annual Meeting of the American Urological Association: San Antonio, TX; May, 2005. 19. Parsons JK, Carter HB, Partin AW, Landis P, Metter EJ, Platz EA. Obesity is associated with increased prostate volume. Annual Meeting of the American Urological Association: San Antonio, TX; May, 2005. 20. Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L, Landis PK, Platz EA. Metabolic factors associated with benign prostatic hyperplasia: the Baltimore Longitudinal Study of Aging. J Urol. 2006;175(4 Suppl):432-433. Abstract 1344. Presented at the Annual Meeting of the American Urological Association; May 23, 2006; Atlanta, GA. 21. Hergan LA, Sakamoto K, Lakin C, Parsons JK. Efficacy of alpha blockers for the treatment of ureteral stones. Presented at the Annual Meeting of the Western Section of the American Urological Association; October, 2006; Maui, HI. 22. Newman V, Parsons JK, Mohler J, Pierce JP, Paskett E, Marshall J. The Men’s Eating and Living (MEAL) study: a multi-center pilot trial of dietary intervention for the treatment of prostate cancer. Presented at the Annual Meeting of the Society of Urologic Oncology; December 2006; Bethesda, MD. 23. Parsons JK, Bennett L. Outcomes of radical retropubic, laparoscopic, and roboticassisted prostatectomy: a quantitative, evidence-based analysis. Presented at the Annual Meeting of the Society of Urologic Oncology; December 2006; Bethesda, MD. 24. Parsons JK, Talalay P, Ye L, Nelson W, Kalish M, Partin A. Cruciferous vegetable extracts for the chemoprevention and treatment of prostate cancer: a pilot study. Presented at the Annual Meeting of the Society of Urologic Oncology; December 2006; Bethesda, MD. 25. Parsons JK, Newman V, Mohler J, Pierce JP, Paskett E, Marshall J. Dietary modification: a novel intervention for prostate cancer patients treated with active surveillance. Presented at University of California, San Francisco Active Surveillance for Early Stage Prostate Cancer Conference; January 12, 2007; San Francisco, CA. 26. Newman V, Parsons JK, Mohler J, Pierce JP, Paskett E, Marshall J. The Men’s Eating and Living (MEAL) study: a multi-center pilot trial of dietary intervention for the treatment of prostate cancer. Presented at the Annual Meeting of the American Association for Cancer Research; April 16, 2007; Los Angeles, CA. 27. Newman V, Parsons JK, Mohler J, Pierce JP, Paskett E, Marshall J. The Men’s Eating and Living (MEAL) study: a multi-center pilot trial of dietary intervention for the 20 J. Kellogg Parsons, M.D., M.H.S. Page 21 treatment of prostate cancer. Presented at the Annual Meeting of the American Urological Association; May 20, 2007; Anaheim, CA. 28. Parsons JK, Bennett L. Outcomes of radical retropubic, laparoscopic, and roboticassisted prostatectomy: a quantitative, evidence-based analysis. Presented at the Annual Meeting of the American Urological Association; May 19, 2007; Anaheim, CA. 29. Parsons JK, Newman V, Mohler J, Pierce JP, Paskett E, Marshall J. Dietary modification: a novel intervention for prostate cancer patients treated with active surveillance. Presented at the Annual Meeting of Western Section American Urological Association; October 30, 2007; Scottsdale, AZ. 30. Parsons JK, Bergstrom J, Barrett-Conner E. Lipids, lipoproteins, and risk of benign prostatic hyperplasia in community dwelling men. Presented at the Annual Meeting of Western Section American Urological Association; October 30, 2007; Scottsdale, AZ. 31. Parsons JK, Bergstrom J, Silberstein J, Barrett-Connor E. Prevalence and characteristics of lower urinary tract symptoms in octogenarian and nonagenarian men. Presented at the Annual Meeting of the American Urological Association: Orlando, FL; May, 2008. 32. Parsons JK, Mougey J, Lambert L, Wilt T, Fink H, Garzotto M, Barrett-Connor E, Marshall L, RCH Group for the Osteoporotic Fractures in Men (MrOS) Research. Lower urinary tract symptoms and risk of falls in older men. Presented at the Annual Meeting of the American Urological Association: Orlando, FL; May, 2008 33. Parsons JK and Im R. Alcohol consumption is associated with decreased risk of benign prostatic hyperplasia. Presented at the Annual Meeting of Western Section American Urological Association; October 2008; Monterrey, CA. 34. Parsons JK, Kwan L, Connor S, Miller DC, Litwin MS. Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providers. Presented at the Annual Meeting of the Society of Urologic Oncology; December 2008; Bethesda, MD. 35. Parsons JK, Im R. Alcohol consumption is associated with decreased risk of benign prostatic hyperplasia. Presented at the Annual Meeting of the American Urological Association; Apr 2009; Chicago, IL. [abstract 1423]. J Urol. 2009;181(4 Suppl):509. 36. Parsons JK, Wilt TJ, Barrett-Connor E, Bauer D, Marshall LM. Incidence of clinically significant lower urinary tract symptoms among older men. Presented at the Annual Meeting of the American Urological Association; Apr 2009; Chicago, IL. [abstract 1651]. J Urol. 2009;181(4Suppl):595. 37. Parsons JK, Kwan L, Connor S, Miller DC, Litwin MS. Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private 21 J. Kellogg Parsons, M.D., M.H.S. Page 22 providers. Presented at the Annual Meeting of the American Urological Association; Apr 2009; Chicago, IL. [abstract 74]. J Urol. 2009;181(4 Suppl):27. 38. Parsons JK, Trifiro MD, Bergstrom J, Palazzi-Churas K, Barrett-Connor E. Serum androgens and risk of lower urinary tract symptoms in community dwelling older men [abstract ]. J Urol. 2009;181(4 Suppl):526. 39. Fujita K, Ewing CM, Getzenberg RH, Parsons JK, Isaacs WB, Pavlovich CP. Monocyte chemotactic protein-1 (MCP-1:CCL2) is associated with prostatic growth dysregulation [abstract 1413]. J Urol. 2009;181(4 Suppl):505. 40. Parsons JK, Fujita K, Ewing CM, Isaacs WB, Pavlovich CP. Prostatic monocyte chemotactic protein-1 (MCP-1): a novel biomarker for lower urinary tract symptoms associated with benign prostatic hyperplasia. Presented at the Annual Meeting of the American Urological Association; Apr 2009; Chicago, IL. [abstract 1652]. J Urol. 2009;181(4 Suppl): 595. 41. Parsons JK, Palazzi-Churas K, Bergstrom J and Barrett-Connor E. Serum androgens and the risk of clinical benign prostatic hyperplasia: a community based study. Presented at the Annual Meeting of the American Urological Association; May 2010; San Francisco, CA. [abstract 1495]. J Urol. 2010 (Vol. 183, Issue 4, Supplement, Page e576) 42. Parsons JK, Wilt TJ, Wang PY, Barrett-Connor E, Bauer DC, and Marshall LM. Prevalence of treatment for lower urinary tract symptoms in community dwelling older men. Presented at the Annual Meeting of the American Urological Association; May 2010; San Francisco, CA. [abstract 1632]. J Urol. 2010 (Vol. 183, Issue 4, Supplement, Page e631). 43. Parsons JK, Wang PY, Bauer DC, Barrett-Connor E, and Marshall LM. Prostate cancer and lower urinary tract symptoms in community dwelling older men. Presented at the Annual Meeting of the American Urological Association; May 2010; San Francisco, CA. [abstract 494]. J Urol. 2010 (Vol. 183, Issue 4, Supplement, Page e195) 44. Parsons JK, Palazzi-Churas K, Bergstrom J, and Barrett-Connor E. A prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study. Presented at the Annual Meeting of Western Section American Urological Association; October 2010; Waikoloa, HI. 45. Woldrich JM, Palazzi-Churas K, Lakin C, Albo M and Parsons JK. Laser photovaporization of the prostate for urinary retention. Presented at the Annual Meeting of Western Section American Urological Association; October 2010; Waikoloa, HI. 46. Kopp RP, Parsons JK, Shiau J, Wang-Rodriguez J, Silberstein JL, Derweesh IH, Cohen SA, Kane CJ, Downs TM, and Sakamoto K. Prostate atypia: clinical and pathologic variables associated with cancer diagnosis on repeat biopsy. Presented at the Annual 22 J. Kellogg Parsons, M.D., M.H.S. Page 23 Meeting of Western Section American Urological Association; October 2010; Waikoloa, HI. 47. Stroup SP, Palazzi-Churas K, Kopp RP, and Parsons JK. Hospital discharge trends in benign prostatic hyperplasia: The National Inpatient Sample, 1998-2007. Presented at the Annual Meeting of Western Section American Urological Association; October 2010; Waikoloa, HI. 48. Parsons JK, Wilt TJ, Wang PY, Barrett-Connor E, Bauer DC, and Marshall LM. Prevalence of treatment for lower urinary tract symptoms in community dwelling older men. Presented at the Annual Meeting of Western Section American Urological Association; October 2010; Waikoloa, HI. 49. Parsons JK, Wang PY, Bauer DC, Barrett-Connor E, and Marshall LM. Prostate cancer and lower urinary tract symptoms in community dwelling older men. Presented at the Annual Meeting of Western Section American Urological Association; October 2010; Waikoloa, HI. 50. Kopp RP, Parsons JK, Partin AW, Humphries E, Freedland SJ, and Han M. Obesity and prostate enlargement in men with localized prostate cancer. Presented at the Annual Meeting of Western Section American Urological Association; October 2010; Waikoloa, HI. 51. Parsons JK, Kwan L, Connor S, Miller DC, Litwin MS. Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providers. Presented at the Annual Meeting of the American Public Health Association; November 2010; Denver, CO. 52. Kopp RP, Parsons JK, Shiau J, Wang-Rodriguez J, Silberstein JL, Derweesh IH, Cohen SA, Kane CJ, Downs TM, and Sakamoto K. Prostate atypia: clinical and pathologic variables associated with cancer diagnosis on repeat biopsy. Presented at the Annual Meeting of the Society of Urologic Oncology; December 2010; Bethesda, MD. 53. Kopp RP, Han M, Partin AW, Humphries E, Freedland SJ, and Parsons JK. Obesity and prostate enlargement in men with localized prostate cancer. Presented at the Annual Meeting of the Society of Urologic Oncology; December 2010; Bethesda, MD. Book Chapters 1. Parsons CL and Parsons JK. Interstitial Cystitis. In: Raz S ed. Female Urology, 2nd ed. Philadelphia: W.B. Saunders, 1996, 167-182. 2. Parsons JK and Partin AW. Management of rising prostate-specific antigen after local surgical therapy. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan 23 J. Kellogg Parsons, M.D., M.H.S. Page 24 WM, eds. Comprehensive Textbook of Genitourinary Oncology, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2006, Chapter 15C, pp. 287-295. 3. Parsons JK, Partin AW, and Walsh PC. Anatomic radical retropubic prostatectomy. In: Prostate Cancer: Principles and Practice, 1st ed. Kirby RS, Partin AW, Feneley MP, Parsons JK, eds. London: Taylor & Francis, 2006, Chapter 72, pp. 715-732. 4. Parsons JK and Partin AW. Clinical interpretation of prostate cancer biopsy reports. In: Prostate Cancer: Principles and Practice, 1st ed. Kirby RS, Partin AW, Feneley MR, Parsons JK eds. London: Taylor & Francis, 2006, Chapter 57, pp. 579-591. 5. Parsons JK and Partin AW. Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy. In: Prostate Cancer: Principles and Practice, 1st ed. Kirby RS, Partin AW, Feneley MR, Parsons JK, eds. London: Taylor & Francis, 2006, Chapter 75, pp. 747-754. 6. Parsons JK and Pinto P. Guide to radiological procedures and nerve blocks. In: The Brady Urology Manual, 1st ed. Parsons JK and Wright EJ, eds. London: Taylor & Francis, 2006, pp. 303-307. 7. Han M, Parsons JK. Prostate cancer: localized. In: The Brady Urology Manual, 1st ed. Parsons JK, Wright EJ, eds. London: Taylor & Francis, 2006, pp. 123-130. 8. Parsons JK. Testicular tumors. In: The Brady Urology Manual, 1st ed. Parsons JK, Wright EJ, eds. London: Taylor & Francis, 2006, pp. 173-184. 9. Parsons JK. Diseases of the adrenal gland. In: The Brady Urology Manual, 1st ed. Parsons JK, Wright EJ, eds. London: Taylor & Francis, 2006, pp. 195-205. 10. Kashefi C, Partin AW, and Parsons JK. Early detection of and screening for prostate cancer. In: Early Diagnosis of Cancer Series: Prostate Cancer. Su LM, ed. In press. Books 1. Penn Med Alpha Omega Alpha Medical Student Handbook. Hersch C and Parsons JK eds. Philadelphia: University of Pennsylvania School of Medicine, 1996. 2. Parsons JK. Penn Med Student Guide to the Clinics. Philadelphia: University of Pennsylvania School of Medicine, 1997. 3. Prostate Cancer: Principles and Practice, 1st ed. Kirby RS, Partin AW, Feneley MR, Parsons JK eds. London: Taylor & Francis, 2006. 4. The Brady Urology Manual, 1st ed. Parsons JK and Wright EJ, eds. London: Taylor & Francis, 2006. 24 J. Kellogg Parsons, M.D., M.H.S. Page 25 5. Treatment Methods for Early and Advanced Prostate Cancer, 1st ed. Kirby RS, Partin AW, Parsons JK, Feneley MR, eds. Informa Healthcare, 2008. Other Publications 1. Parsons JK. Diffusion of new technology for benign prostatic hyperplasia and prostatitis. In: NIDDK Prostate Research Strategic Plan. Bethesda, MD: 2008, pp. 49-51. 2. Parsons JK, Mohler J, and Marshall J. Prostate cancer and diet: where do we go from here? AUANews, March 2011. 25